Protein kinase C regulates cytokine-induced tissue factor transcription and procoagulant activity in human endothelial cells

Journal of Laboratory and Clinical Medicine

Volumn 127, Issue 1, 1996, Pages 81-93

  Terry, Christi M ^a   Callahan, Karleen S ^a,b  

^a University of Utah School of Medicine ^*

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CALPHOSTIN COMPLEX; CYTOKINE; ETHER DERIVATIVE; INTERLEUKIN 1; MESSENGER RNA; NAPHTHALENE DERIVATIVE; OKADAIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTACYCLIN; PROTEIN KINASE C; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; BLOOD CLOTTING; CELL ADHESION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; NEUTROPHIL; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

BLOOD COAGULATION; CALCIMYCIN; CELL ADHESION; CYTOKINES; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; ETHERS, CYCLIC; HUMANS; INTERLEUKIN-1; NAPHTHALENES; NEUTROPHILS; OKADAIC ACID; PROTEIN KINASE C; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; THROMBOPLASTIN; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030040021     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90169-9     Document Type: Article

References (20)

1. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA, Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618-23.
2. Nawroth PP, Stem DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163:740-5.
3. Colucci M, Balconi G, Lorenzet R, et al. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983;71:1893-6.
4. Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986;137:1532-7.
5. Uchman B, Bang NU, Rathbun MJ, Fineberg NS, Davidson JK, Fineberg SE. Effect of insulin immune complexes on human blood monocyte and endothelial cell procoagulant activity. J LAB CLIN MED 1988;112:652-9.
6. Magnuson DK, Maier RV, Pohlman T. Protein kinase C: a potential pathway of endothelial cell activation by endotoxin, tumor necrosis factor, and interleukin-1. Surgery 1989;106: 216-22.
7. Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties: modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 1989;264:20705-13.
8. Crossman DC, Carr DP, Tuddenham EGD, Pearson JD, McVey JH. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990;265:9782-7.
9. Lane TA, Lamkin GE, Wancewica EV. Protein kinase C inhibitors block the enhanced expression of intercellular adhesion molecule-1 on endothelial cells activated by interleukin-1, lipopolysaccharide and tumor necrosis factor. Biochem Biophys Res Comm 1990;172:1273-81.
10. Lyberg T, Galdal KS, Evensen SA, Prydz H. Cellular cooperation in endothelial cell thromboplastin synthesis. Br J Haematol 1983;53:85-95.
11. Nawroth PP, Stern DM, Kisiel W, Bach R. Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture. Thromb Res 1985;40:677-91.
12. Zuckerman SH, Suprenant YM. Augmentation of procoagulant activity in monokine stimulated human endothelial cells by calmodulin/protein kinase C. Thromb Res 1988;49:205-14.
13. Pettersen KS, Wiiger MT, Narahara N, Andoh K, Gaudernack G, Prydz H. Induction of tissue factor synthesis in human umbilical vein endothelial cells involves protein kinase C. Thromb Haemost 1992;67:473-7.
14. Hidaka H, Inagaki M, Kawamoto S, Sasaki Y. Isoquinoline-sulfonamides, novel potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 1984;23:5036-41.
15. Ruegg UT, Burgess GM. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci 1989;10:218-20.
16. Archipoff G, Beretz A, Bartha K, et al. Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities. Br J Pharmacol 1993;109:18-28.
17. Kobayashi E, Nakamo H, Morimoto M, Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989;159:548-53.
18. Rapaport SI, Rao LVM. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992;12:1111-21.
19. Callahan KS, Schorer A, Harlan JM. Platelet-derived growth factor does not stimulate prostacyclin synthesis by cultured endothelial cells. Blood 1986;67:131-4.
20. Bruns RF, Miller DF, Merriman RL, et at. Inhibition of protein kinase C by calphostin C is light-dependent. Biochem Biophys Res Comm 1991;176:288-93.